Showing results (1971-1980 of 2,925) with videos related to

Sort By:
Pageof 293
American Journal of Medical Genetics|June 28, 1996
Genetic counseling of isolated carriers of Duchenne muscular dystrophyE P Hoffman, E Pegoraro, P Scacheri, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Validation of a single-patient drug trial methodology for personalized management of gastroesophageal reflux diseaseBarbara Wolfe, Eve Del Rio, Sidney L Weiss, et al.
The Journal of Biological Chemistry|December 21, 2012
Neutron and X-ray crystal structures of a perdeuterated enzyme inhibitor complex reveal the catalytic proton network of the Toho-1 β-lactamase for the acylation reactionStephen J Tomanicek, Robert F Standaert, Kevin L Weiss, et al.
Molecular Immunology|May 1, 1985
Mouse monoclonal antibodies to the human C3b receptorJ Cook, E Fischer, C Boucheix, et al.
The American Journal of Gastroenterology|March 1, 1987
The liver in acquired immune deficiency syndrome: emphasis on patients with intravenous drug abuseB M Dworkin, R E Stahl, M A Giardina, et al.
NPJ Microgravity|June 3, 2023
Perfect Crystals: microgravity capillary counterdiffusion crystallization of human manganese superoxide dismutase for neutron crystallographyWilliam E Lutz, Jahaun Azadmanesh, Jeffrey J Lovelace, et al.
Cancer Letters|September 26, 2025
Cancer-associated fibroblast secreted DKK1 promotes the immunosuppressive tumor microenvironment and colorectal cancer resistance to chemotherapyZhijie Yin, Yuning Zhou, Xudong Zhu, et al.
Scientific Reports|January 23, 2020
Differential Abundance Analysis with Bayes Shrinkage Estimation of Variance (DASEV) for Zero-Inflated Proteomic and Metabolomic DataZhengyan Huang, Andrew N Lane, Teresa W-M Fan, et al.
Research Square|September 5, 2025
Comparative genomics and transcriptomics of the Spiroplasma glossinidia strain sGff reveal insights into host interaction and trypanosome resistance in Glossina fuscipes fuscipesDaniel J Bruzzese, Fabian Gstöttenmayer, Brian L Weiss, et al.
The Journal of Infectious Diseases|May 24, 2000
High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapyL Bélec, C Piketty, A Si-Mohamed, et al.
Pageof 293